Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Carlisle Companies | CSL | Aug 30, 2024 | 423.80 | +2.49 |
Carlyle Credit Income Fund | CCIF | Aug 30, 2024 | 8.65 | +2.98 |
Carlyle Credit Income Fund | CCIA | Aug 30, 2024 | 25.79 | -0.83 |
Carlyle Secured Lending | CGBD | Aug 30, 2024 | 16.97 | +0.89 |
CarMax | KMX | Aug 30, 2024 | 84.55 | -0.89 |
Carmell | CTCX | Aug 30, 2024 | 0.64 | +16.00 |
Carnival | CCL | Aug 30, 2024 | 16.50 | -0.24 |
Carnival ADR | CUK | Aug 30, 2024 | 15.05 | -0.20 |
CarParts.com | PRTS | Aug 30, 2024 | 0.80 | -3.30 |
Carpenter Technology | CRS | Aug 30, 2024 | 144.77 | +1.49 |
Carriage Services | CSV | Aug 30, 2024 | 33.15 | +0.79 |
Carrier Global | CARR | Aug 30, 2024 | 72.78 | +2.38 |
Cars.com | CARS | Aug 30, 2024 | 17.84 | 0.00 |
Carter Bankshares | CARE | Aug 30, 2024 | 17.30 | +0.64 |
Carters | CRI | Aug 30, 2024 | 65.90 | -0.14 |
Cartesian Growth II A | RENE | Aug 30, 2024 | 11.38 | 0.00 |
Cartesian Growth II Unit | RENEU | Aug 30, 2024 | 11.38 | 0.00 |
Cartesian Therapeutics | RNAC | Aug 30, 2024 | 13.96 | -6.37 |
Cartica Acquisition A | CITE | Aug 30, 2024 | 11.37 | 0.00 |
Carvana | CVNA | Aug 30, 2024 | 150.62 | +0.36 |
Carver Bancorp | CARV | Aug 30, 2024 | 1.95 | -0.84 |
Casella Waste Systems A | CWST | Aug 30, 2024 | 107.86 | +1.08 |
Caseys General Stores | CASY | Aug 30, 2024 | 362.31 | +0.97 |
CASI Pharmaceuticals | CASI | Aug 30, 2024 | 6.59 | +0.76 |
Cass Information Systems | CASS | Aug 30, 2024 | 43.44 | +0.81 |
Cassava Sciences | SAVA | Aug 30, 2024 | 28.71 | +0.70 |
Castellum | CTM | Aug 30, 2024 | 0.17 | -2.47 |
Castle Biosciences | CSTL | Aug 30, 2024 | 29.67 | -0.40 |
Castor Maritime | CTRM | Aug 30, 2024 | 4.54 | -0.87 |
Catalent | CTLT | Aug 30, 2024 | 60.96 | +0.02 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.